TWI609962B - 細胞培養基之病毒過濾 - Google Patents

細胞培養基之病毒過濾 Download PDF

Info

Publication number
TWI609962B
TWI609962B TW102121710A TW102121710A TWI609962B TW I609962 B TWI609962 B TW I609962B TW 102121710 A TW102121710 A TW 102121710A TW 102121710 A TW102121710 A TW 102121710A TW I609962 B TWI609962 B TW I609962B
Authority
TW
Taiwan
Prior art keywords
virus
filtration
cell culture
filter
culture medium
Prior art date
Application number
TW102121710A
Other languages
English (en)
Chinese (zh)
Other versions
TW201412986A (zh
Inventor
沃夫岡 孟德
阿特 密特瑞
曼福烈 萊特
曼哈德 赫斯拉雀爾
李奧波 葛里柏格
湯瑪士 克萊爾
Original Assignee
巴克斯歐塔公司
巴克斯歐塔有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 巴克斯歐塔公司, 巴克斯歐塔有限公司 filed Critical 巴克斯歐塔公司
Publication of TW201412986A publication Critical patent/TW201412986A/zh
Application granted granted Critical
Publication of TWI609962B publication Critical patent/TWI609962B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/26—Conditioning fluids entering or exiting the reaction vessel
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M37/00—Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
    • C12M37/02—Filters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Filtering Materials (AREA)
TW102121710A 2012-06-21 2013-06-19 細胞培養基之病毒過濾 TWI609962B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261662814P 2012-06-21 2012-06-21
US61/662,814 2012-06-21

Publications (2)

Publication Number Publication Date
TW201412986A TW201412986A (zh) 2014-04-01
TWI609962B true TWI609962B (zh) 2018-01-01

Family

ID=48672845

Family Applications (2)

Application Number Title Priority Date Filing Date
TW102121710A TWI609962B (zh) 2012-06-21 2013-06-19 細胞培養基之病毒過濾
TW106136343A TWI698522B (zh) 2012-06-21 2013-06-19 細胞培養基之病毒過濾

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW106136343A TWI698522B (zh) 2012-06-21 2013-06-19 細胞培養基之病毒過濾

Country Status (27)

Country Link
US (3) US9670456B2 (enExample)
EP (2) EP3103861B1 (enExample)
JP (3) JP6220392B2 (enExample)
KR (2) KR102008048B1 (enExample)
CN (2) CN104640969A (enExample)
AR (1) AR092847A1 (enExample)
AU (2) AU2013277532B2 (enExample)
BR (1) BR112014031842B1 (enExample)
CA (1) CA2876473C (enExample)
CO (1) CO7151484A2 (enExample)
DK (2) DK3103861T3 (enExample)
EA (2) EA033006B1 (enExample)
ES (2) ES2829968T3 (enExample)
HR (1) HRP20161435T1 (enExample)
HU (1) HUE031601T2 (enExample)
IL (2) IL236073B (enExample)
IN (1) IN2014DN10441A (enExample)
MX (2) MX347319B (enExample)
MY (2) MY173835A (enExample)
NZ (1) NZ629083A (enExample)
PL (2) PL3103861T3 (enExample)
PT (2) PT2732020T (enExample)
SG (2) SG10201701721TA (enExample)
SI (1) SI2732020T1 (enExample)
TW (2) TWI609962B (enExample)
WO (1) WO2013192009A1 (enExample)
ZA (1) ZA201409253B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2732020T1 (sl) * 2012-06-21 2017-03-31 Baxalta GmbH Filtracija virusa iz gojišča celične kulture
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
SG10201507931QA (en) * 2014-12-22 2016-07-28 Emd Millipore Corp Removal of microorganisms from cell culture media
JP7133925B2 (ja) * 2015-03-23 2022-09-09 アレクシオン ファーマシューティカルズ インコーポレイテッド ウイルス濾過
EP3015542A1 (de) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
TWI797060B (zh) 2015-08-04 2023-04-01 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
KR102414290B1 (ko) * 2016-04-15 2022-06-29 베링거 인겔하임 인터내셔날 게엠베하 세포 보유 장치 및 방법
WO2018107099A1 (en) * 2016-12-09 2018-06-14 Lonza Ltd Method for the reduction of viral titer in pharmaceuticals
KR102782655B1 (ko) * 2017-07-06 2025-03-14 리제너론 파마슈티칼스 인코포레이티드 당단백질을 만들기 위한 세포 배양 과정
TWI898645B (zh) * 2018-05-04 2025-09-21 美商健臻公司 灌注式細胞培養裝置
SG11202109877RA (en) * 2019-03-11 2021-10-28 Genzyme Corp Tangential viral filtration
WO2020205928A1 (en) * 2019-04-03 2020-10-08 Genzyme Corporation Continuous production of recombinant proteins
US12297451B1 (en) 2019-10-25 2025-05-13 Regeneron Pharmaceuticals, Inc. Cell culture medium
WO2021231956A1 (en) * 2020-05-14 2021-11-18 North Carolina State University Fast automated approach for the derivation of acellular extracellular matrix scaffolds from tissues
MX2023003868A (es) * 2020-10-02 2023-06-07 Regeneron Pharma Filtracion con retencion de virus continua.
WO2025019797A2 (en) * 2023-07-19 2025-01-23 Hatchless Inc. System and method for low-cost sterilization of liquids

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1457497A1 (en) * 2003-03-06 2004-09-15 Probitas Pharma, S.A. Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process
EP1775016A1 (en) * 2005-10-14 2007-04-18 Millipore Corporation Ultrafiltration membranes rendered hydrophilic by hydroxyalkyl cellulose and method of making and use of such membranes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0422874A (ja) * 1990-05-16 1992-01-27 Matsushita Electric Ind Co Ltd 波形表示装置
GB2352652A (en) * 1999-08-06 2001-02-07 Fsm Technologies Ltd Pre-treating hollow fibre membranes for micro-organism detection
US6485686B1 (en) * 1999-09-17 2002-11-26 The United States Of America As Represented By The Secretary Of The Army Method and apparatus for counting submicron sized particles
AU1811301A (en) 1999-12-02 2001-06-12 General Hospital Corporation, The Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
US6485688B1 (en) 2000-04-24 2002-11-26 General Electric Company On-line sparging sampling and monitoring systems and methods
US6630016B2 (en) * 2002-01-31 2003-10-07 Koslow Technologies Corp. Microporous filter media, filtration systems containing same, and methods of making and using
US6835311B2 (en) * 2002-01-31 2004-12-28 Koslow Technologies Corporation Microporous filter media, filtration systems containing same, and methods of making and using
PT1711513E (pt) 2003-12-01 2014-10-02 Novo Nordisk Healthcare Ag Nanofiltração de soluções de fator vii para remover vírus
DE102005047301B4 (de) * 2005-09-30 2009-04-16 Sartorius Stedim Biotech Gmbh Verfahren zum Nachweis der Virenabreicherung für die Validierung von Filtern und Filtrationsprozessen
US8309029B1 (en) * 2009-03-26 2012-11-13 The United States Of America As Represented By The Secretary Of The Army Virus and particulate separation from solution
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
CN106008697B (zh) * 2009-08-20 2020-08-04 百深公司 纯化vwf以增加非-脂质包封的病毒的去除
SI2732020T1 (sl) * 2012-06-21 2017-03-31 Baxalta GmbH Filtracija virusa iz gojišča celične kulture

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1457497A1 (en) * 2003-03-06 2004-09-15 Probitas Pharma, S.A. Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process
EP1775016A1 (en) * 2005-10-14 2007-04-18 Millipore Corporation Ultrafiltration membranes rendered hydrophilic by hydroxyalkyl cellulose and method of making and use of such membranes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Liu S et al., "Development and Qualification of a Novel Virus Removal Filter for Cell Culture Applications", Biotechnol. Prog., vol.16, p.425-434, 2000/03/05 *

Also Published As

Publication number Publication date
AR092847A1 (es) 2015-05-06
KR102008048B1 (ko) 2019-08-06
MX347319B (es) 2017-04-21
AU2013277532A1 (en) 2015-01-15
JP2019022526A (ja) 2019-02-14
EP2732020A1 (en) 2014-05-21
MX2014015950A (es) 2015-07-17
BR112014031842B1 (pt) 2020-09-15
US11421202B2 (en) 2022-08-23
JP6220392B2 (ja) 2017-10-25
CA2876473A1 (en) 2013-12-27
US20130344535A1 (en) 2013-12-26
CA2876473C (en) 2021-05-11
BR112014031842A2 (pt) 2017-08-22
AU2013277532B2 (en) 2017-06-15
DK3103861T3 (da) 2020-11-16
US20200277565A1 (en) 2020-09-03
IL236073B (en) 2019-01-31
JP2017184765A (ja) 2017-10-12
CN108795724A (zh) 2018-11-13
IN2014DN10441A (enExample) 2015-08-21
ES2829968T3 (es) 2021-06-02
EA201990887A1 (ru) 2019-08-30
NZ629083A (en) 2016-11-25
HUE031601T2 (hu) 2017-07-28
TW201412986A (zh) 2014-04-01
TWI698522B (zh) 2020-07-11
KR20150032709A (ko) 2015-03-27
EP3103861A1 (en) 2016-12-14
AU2017228547B2 (en) 2019-02-21
CO7151484A2 (es) 2014-12-29
ZA201409253B (en) 2022-05-25
EP3103861B1 (en) 2020-09-30
HK1198335A1 (zh) 2015-04-02
IL263479B (en) 2020-08-31
PL2732020T3 (pl) 2017-06-30
WO2013192009A1 (en) 2013-12-27
ES2601429T3 (es) 2017-02-15
MY195362A (en) 2023-01-16
EA033006B1 (ru) 2019-08-30
MY173835A (en) 2020-02-24
SG11201408490PA (en) 2015-01-29
EP2732020B1 (en) 2016-08-10
HRP20161435T1 (hr) 2017-02-24
IL263479A (en) 2019-01-31
PT3103861T (pt) 2020-11-16
US20170260498A1 (en) 2017-09-14
CN104640969A (zh) 2015-05-20
SI2732020T1 (sl) 2017-03-31
EA201590059A1 (ru) 2015-04-30
PL3103861T3 (pl) 2021-03-22
DK2732020T3 (en) 2016-11-28
TW201816105A (zh) 2018-05-01
US9670456B2 (en) 2017-06-06
JP6557706B2 (ja) 2019-08-07
HK1231502A1 (en) 2017-12-22
AU2017228547A1 (en) 2017-10-05
KR20190092618A (ko) 2019-08-07
JP2015529447A (ja) 2015-10-08
IL236073A0 (en) 2015-01-29
PT2732020T (pt) 2016-11-10
SG10201701721TA (en) 2017-04-27
MX386767B (es) 2025-03-19

Similar Documents

Publication Publication Date Title
TWI609962B (zh) 細胞培養基之病毒過濾
AU2004263813B2 (en) Methods of producing influenza vaccine compositions
AU2015217006A1 (en) Ultrafiltration unit for continuous buffer or media exchange from a protein solution
RU2461629C2 (ru) Среды для культур клеток млекопитающих, которые содержат надосадочную жидкость стадий фракционирования по кону, и их применение
US11052165B2 (en) Method for virus clearance
HK1231502B (en) Virus filtration of cell culture media
KR102817858B1 (ko) 베로 세포 배양용 저혈청 배지 조성물 및 이의 이용
HK1198335B (en) Virus filtration of cell culture media
EA042527B1 (ru) Вирусная фильтрация сред клеточных культур
Festen Understanding animal sera: considerations for use in the production of biological therapeutics
Nikolay Intensified yellow fever and Zika virus production in animal cell culture
Gränicher Process intensification and integration for the production of vaccines and viral vectors
Durrani et al. Non-animal peptone for serum free cultivation of recombinant mammalian and animal cells
Vázquez Ramírez Process intensification for the production of MVA and influenza A virus in high density suspension cultures of AGE1. CR. pIX cells